Sat Jul 4 09:39:06 SGT 2015  
HEPATITIS
B
    Hepatitis B, Jamaica
HIV PEP (post-exposure prophylaxis): Stop HIV infection within 3 days after unprotected sex.
HIV test: 20 minute rapid test to accurately detect HIV infection 28 days after unprotected sex.
STD testing: Full & comprehensive sexually transmitted disease testing.

Hepatitis B, Jamaica

Summary

Hepatitis B, Jamaica @hepatitisb_biz: Hepatitis B symptoms in men/women, screening/diagnosis, testing/check and treatment, Jamaica - Private and confidential service.

Keywords: Hepatitis B Jamaica, Jamaica Hepatitis B, Hepatitis B.

Description

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
HIV STD TESTING TREATMENT™
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Hepatitis B, Jamaica
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Budget airlines based in Singapore:

Budget airlines operating in Singapore:

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception (females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing.
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception (females only)
2 weeks HIV DNA PCR test
1 month 20 minute HIV rapid test - SD Bioline HIV Ag/Ab Combo:
- Fingerprick blood sampling.
3 months 20 minute HIV rapid test - OraQuick®:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

Location reference


Latest News

Survey of Immunization Practices in Patients With Inflammatory Bowel Disease Among Pediatric Gastroenterologists
Wed, 01 Jul 2015 05:00:00 +0100 | Journal of Pediatric Gastroenterology and Nutrition
Conclusions: There is practice variation among pediatric gastroenterologists in assessment of immunizations in patients with inflammatory bowel disease, including the specific vaccines assessed, and timing and method of assessment. Inability to coordinate care, access immunization records, and offer vaccines through their medical practice are barriers to adhering to immunization guidelines. (Source: Journal of Pediatric Gastroenterology and Nutrition)

[PERSPECTIVES] Hepadnavirus Genome Replication and Persistence
Wed, 01 Jul 2015 00:00:00 +0100 | Cold Spring Harbor perspectives in medicine
Hallmarks of the hepadnavirus replication cycle are the formation of covalently closed circular DNA (cccDNA) and the reverse transcription of a pregenomic RNA (pgRNA) in core particles leading to synthesis of the relaxed circular DNA (rcDNA) genome. cccDNA, the template for viral RNA transcription, is the basis for the persistence of these viruses in infected hepatocytes. In this review, we summarize the current state of knowledge on the mechanisms of hepadnavirus reverse transcription and the biochemical and structural properties of the viral reverse transcriptase (RT). We highlight important gaps in knowledge regarding cccDNA biosynthesis and stability. In addition, we discuss the impact of current antiviral therapies on viral persistence, particularly on cccDNA. (Source: Cold Spring Har...

[PERSPECTIVES] Hepatitis D Virus: Introduction and Epidemiology
Wed, 01 Jul 2015 00:00:00 +0100 | Cold Spring Harbor perspectives in medicine
Hepatitis D is caused by the hepatitis D virus (HDV), a unique RNA pathogen that requires the hepatitis B surface antigen (HBsAg) to infect. Hepatitis D is transmitted by the parenteral route. The main susceptible group is patients with chronic HBsAg infection who become superinfected with the virus. Hepatitis D occurs throughout the globe, but control of hepatitis B virus (HBV) in the last two decades has consistently diminished the circulation of HDV in industrialized countries. However, hepatitis D remains a medical issue for injecting drug users (IDUs), as well as immigrants from endemic HDV areas, who are reintroducing the infection in Europe. (Source: Cold Spring Harbor perspectives in medicine)

Fibromyalgia incidence among patients with hepatitis B infection
Wed, 01 Jul 2015 00:00:00 +0100 | APLAR Journal of Rheumatology
ConclusionsThe results of the present study demonstrate that FMS incidence is greater among HBV patients relative to control subjects. However, there were no differences in FMS incidence among the subgroups of HBV diagnoses. (Source: APLAR Journal of Rheumatology)

Comparing Humoral and Cellular Immune Response Against HBV Vaccine in Kidney Transplant Patients
Wed, 01 Jul 2015 00:00:00 +0100 | American Journal of Transplantation
In conclusion, mounting of hepatitis B vaccine‐specific T cell responses is possible in kidney transplant recipients despite immunosuppression. Detection of HBV‐specific Th‐cells in a significant proportion of humoral NRs contributes to the current discussion on conferring immune protection by cellular memory in such patients. (Source: American Journal of Transplantation)

A major shift of viral and nutritional risk factors affects the hepatocellular carcinoma risk among Ivorian patients: a preliminary report
Tue, 30 Jun 2015 00:00:00 +0100 | Infectious Agents and Cancer
In conclusion, our work indicates that HCC epidemiology underwent recently major drifts in Ivory Coast. (Source: Infectious Agents and Cancer)

Complement C4a Inhibits the Secretion of Hepatitis B Virus Screened by Surface‐enhanced Laster Desorption Ionization Time‐Flight Mass Spectrometry (SELDI)‐based ProteinChip Analysis
Mon, 29 Jun 2015 00:00:00 +0100 | Proteomics. Clinical Applications
Conclusions and clinical relevance: The present study implied the important role of complement C4a in inhibiting the HBV DNA secretion in CHB.This article is protected by copyright. All rights reserved (Source: Proteomics. Clinical Applications)

Inhibition of microRNA‐214 ameliorates hepatic fibrosis and tumor incidence in platelet‐derived growth factor C transgenic mice
Mon, 29 Jun 2015 00:00:00 +0100 | Cancer Science
In conclusion, miR‐214 appears to participate in the development of hepatic fibrosis by modulating the EGFR and TGF‐β signaling pathways. LNA‐antimiR‐214 may be a potentially therapy in the prevention of hepatic fibrosis.

Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update [ASCO SPECIAL ARTICLES]
Mon, 29 Jun 2015 00:00:00 +0100 | Journal of Clinical Oncology
Purpose

Chronic hepatitis B: Are we close to a cure?
Mon, 29 Jun 2015 00:00:00 +0100 | Digestive and Liver Disease
Approximately 300 million people worldwide are persistently infected with the hepatitis B virus and are at risk of developing hepatocellular carcinoma and liver cirrhosis, which can progress to end-stage liver disease. Despite the effectiveness of the current vaccination policy, the prevalence of the disease remains high, and the burden for health services is considerable. The currently available antiviral strategies are either poorly effective or only effective for non-curative suppression of viral replication. (Source: Digestive and Liver Disease)